A Study of HA121-28 Tablets in Advanced Biliary Tract Cancer

Clinical trial NCT04784520 · TERMINATED

Trial details

NCT number: NCT04784520
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Biliary Tract Cancer

Start date: 2021-06-22
Primary completion: 2022-12-28
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.